Boyi Gan, PhD
@boyigan
Professor & Director, Radiation and Cancer Metabolism Program @MDAndersonNews. Research topic: #ferroptosis, #cancer #metabolism. @cornell @DanaFarber alum.
ID: 1064285725951238144
https://www.mdanderson.org/research/departments-labs-institutes/labs/gan-laboratory.html 18-11-2018 22:34:25
401 Tweet
1,1K Followers
277 Following
Great honor to present at NIH Intramural! Thanks @WeyemiLab for the invitation.
Congrats to these MD Anderson Cancer Center faculty in #radonc for being recognized at the Faculty Excellence Celebration this year! #endcancer
Look forward to presenting our research at NIH Intramural @NCIResearchCtr @WeyemiLab tomorrow.
Congratulations to Dr. Junjie Chen on his NCI R35 Outstanding Investigator Award! Dr. Chen is not only a leader in his field, but he is also operating his department at MD Anderson Cancer Center exceptionally well, creating an outstanding environment where his faculty recruits flourish.
Glad to be part of Acquired Resistance to Therapy Network (ARTNet) and establish ARTI Center to target #ferroptosis in #radioresistance and #drugresistance. MD Anderson Cancer Center Albert Koong, MD PhD Dadi Jiang Steven H. Lin #endcancer.
Our 4th most downloaded article in 2022: Targeting ferroptosis as a vulnerability in cancer by Boyi Gan, PhD & colleagues. go.nature.com/3tZAnVv Cancer at Nature Portfolio MD Anderson Cancer Center #NRCtop10of2022 pic.x.com/kuE4TEk7x2
“This important finding will hopefully inspire disulfidptosis-inducing treatments for cancers that have evaded other therapies and are resistant to apoptosis,” says our Dr. Boyi Gan. Learn about his team's insights here: fal.cn/3vERI Boyi Gan, PhD #Research #EndCancer
Our new publication in Nature Cell Biology identifies #disulfidptosis as a new form of cell death induced by excessive disulfide molecules in cells. We also suggest to explore this cell death in cancer therapy. MD Anderson Cancer Center #endcancer nature.com/articles/s4155…
📢Latest Nature Cell Biology: "Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis" by Xiaoguang Liu, Litong Nie, Junjie Chen, Boyi Gan, PhD & co. from MD Anderson Cancer Center #celldeath #CancerResearch nature.com/articles/s4155…
"Here at MD Anderson, our study of ferroptosis continues to improve how we can use it in cancer treatment so that we will, hopefully, one day, achieve our goal to end cancer," says our Dr. Boyi Gan. Learn about ferroptosis here: fal.cn/3xnU1 Boyi Gan, PhD #EndCancer
This afternoon, Boyi Gan, PhD from MD Anderson is discussing how to target #ferroptosis vulnerability in cancer therapy in session ED012 at the #AACR23 meeting. Learn more about ferrotopsis from Dr. Gan here: bit.ly/3GDnzd6 #EndCancer
What is ferroptosis? And how it is used to treat cancer? Our Dr. Boyi Gan shares his insights: fal.cn/3y3Be Boyi Gan, PhD #CancerResearch #EndCancer
Out today Nature Communications an elegant study by ARTNet PI Boyi Gan, PhD & team MD Anderson Cancer Center that unveiled how expression levels of SLC7A11 a Cysteine/Glutamate transporter can dictate sensitivity of cancer cells to oxidative stress, More info👉 rb.gy/bt0lc
The level of cystine transporter SLC7A11 leads to different outcomes in primary tumours and metastasis nature.com/articles/s4146… #CancerResearch Cancer at Nature Portfolio Boyi Gan, PhD MD Anderson Cancer Center
Our new publication in Nature Communications reveals a counterintuitive finding that high overexpression of the cystine transporter SLC7A11/xCT promotes H2O2-induced #disulfidptosis and impairs tumor metastasis. nature.com/articles/s4146… MD Anderson Cancer Center #endcancer
Chairs Katharina Schlacher (MDACC) & A. Phillip West have pulled together leading researchers across various fields, to develop a wholistic understanding of organelle crosstalk and it's impacts on cancer, metabolic & neurologic diseases, as well as aging. 🎙️Talk submission closes
